KAPA

Kairos Pharma, Ltd. (KAPA)

US
$ 1.02-1.92%

Price Chart

Key Statistics

Market Cap
$ 18.77M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
82.44K
52W High
$ 4.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
1.5408
200-Day MA
1.5758
52 Week High
4
52 Week Low
N/A

About KAPA

Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops therapeutics for cancer patients.

Employees
1
Headquarters
Los Angeles, CA
CEO
Dr. John S. Yu M.D., Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg